In human cells, under physiological conditions, TDP-43 mainly localizes in the nucleus, but in neurons and glial cells of ALS and FTD patients it shuttles and accumulates in the cytoplasm where eventually aggregates and contribute to the onset and progression of these diseases18–22. This evidence concerns the gene TARDBP and frontotemporal dementia.